Thus, behind the scenes of mutual exclusion for SOX2 amplification and YAP1 amplification of these patients in this study, there lies a unique unknown molecular mechanism of ESCC tumorigenesis, distinguished from other cancer types, which needs further investigation. This evidence concerns the gene YAP1 and esophageal squamous cell carcinoma.